✨ Janux, JANX008 1상 연구에서 1a상 용량 증량 완료; 확장 코호트 개시
★ 56 전문 정보 ★
(RTTNews) – Janux Therapeutics, Inc. (JANX), a clinical-stage biopharmaceutical company, provided an update that the Phase 1a dose-escalation portion of the ongoing Phase 1 study evaluating JANX008 across multiple solid tumour indications has been completed. In addition, the prog
🎯 핵심 특징
✅ 고품질
검증된 정보만 제공
⚡ 빠른 업데이트
실시간 최신 정보
💎 상세 분석
전문가 수준 리뷰
📖 상세 정보
(RTTNews) – Janux Therapeutics, Inc. (JANX), a clinical-stage biopharmaceutical company, provided an update that the Phase 1a dose-escalation portion of the ongoing Phase 1 study evaluating JANX008 across multiple solid tumour indications has been completed. In addition, the prog